On the heels of President Biden’s announcement that he was asking the Secretary of Health and Human Services and the Attorney General to “expeditiously” review the scheduling of cannabis under federal law, Alex Malyshev and Sarah Ganley of Carter Ledyard’s Cannabis, Hemp & CBD Industry Group consider what the rescheduling of cannabis, from Schedule I to Schedule II, might mean for the industry.
